MIF and breast carcinoma: By screening various cancer cell lines with different genetic backgrounds regardless of tissue origin, hormone responsiveness or competitively binding to mPRα, PRG and MIF can act as negative regulators of proliferation for controlling breast cancer cells [94,95] or negative regulators of apoptosis to protect neuronal cells [96,97].